Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases

Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases

Targeting the vascular endothelial growth factor-mediated immune suppression is a strategy to overcome the resistance of anti-programmed cell death protein 1/programmed death-ligand 1 (anti-PD-1/PD-L1) therapy. Here, we present two cases, including one case with leiomyosarcoma and the other one with...

Full description

Saved in:
Bibliographic Details
Main Authors: Bing-Syuan Chung, Peng-Chan Lin, Shang-Hung Chen, Yu-Min Yeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-10-01
Series:Journal of Cancer Research and Practice
Subjects:
colorectal cancer
immunotherapy
leiomyosarcoma
tumor microenvironment
vascular endothelial growth factor-targeted therapy
Online Access:https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00016
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00016

Similar Items